A significant shift in Canadian drug policy has happened, as the government allow the availability of psilocybin mushrooms for therapeutic applications. Until now, these substances were heavily restricted, but a growing body of studies suggests they may offer aid for psychological conditions like PTSD. This change represents a major step toward re-